Product News

Servier Laboratories (Ireland) Ltd is delighted to announce that Lipertance, the combination of atorvastatin, perindopril and amlodipine1, will be available

AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of

Clonmel Healthcare are delighted to announce the introduction of Oyavas®, the new Bevacizumab biosimilar.   Oyavas® is an anti-VEGF monoclonal

In December of last year, Ireland’s international research-based biopharmaceutical industry rolled out a new set of films, telling an impact

Enzalutamide is now the only oral therapy approved by the European Commission to treat three distinct types of advanced prostate

Infections caused by antibiotic resistant bacteria, including MRSA, are responsible for 25,000 deaths per year in the EU Research led

Clonmel Healthcare are pleased to unveil the new packaging for Caldease 15% w/w Medicated Ointment. On the market since 1986,